Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 27 Jun 2018 for Outlook Therapeutics, Inc., €5,560.
Filing timeline
BuySaleKenneth Bahrt
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
No signal scores available.
Kenneth Bahrt: trading record in brief
Kenneth Bahrt is a declared insider of Outlook Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 21 December 2016 to 25 June 2018.
No open-market purchase appears, only 2 sales worth €30k. Other entries cover 1 share grant. 2018 to date brings no purchases and 1 sale.
The latest filing, published on 27 June 2018, reports an open-market sale of €5,560 in Outlook Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kenneth Bahrt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
7,700 shares@ US$0.845118.2% of flowCommon StockSEC:0001209191-18-039725:0
26,165 shares@ US$1.13Common StockSEC:0001209191-17-067233:0
50,000 shares0Common StockSEC:0001209191-16-156578:0
3 of 3 declarations
